baber/WOPTO huggingface dataset:
Patent FI-971758-A0 (FI)
Inventor: FROST DOUGLAS ROBERT DAVID
IPC: E03D1/14
Filed: 1997-04-24
Abstract: PCT No. PCT/GB95/02493 Sec. 371 Date Aug. 8, 1997 Sec. 102(e) Date Aug. 8, 1997 PCT Filed Oct. 23, 1995 PCT Pub. No. WO96/14479 PCT Pub. Date May 17, 1996An improved discharge valve comprises an upper housing, an upwardly movable main valve assembly within the housing and forming with the upper part thereof a variable volume upper chamber, a restricted passage between the upper chamber and the exterior thereof, an outlet leading down from the lower part of the housing, a seat for the main valve assembly at the entry to the outlet so that, in the lowered position of the main valve assembly, the outlet is blocked against ingress of fluid in which the device is immersed, and a pilot stem actuable remotely from the housing to put the upper chamber in free communication with the outlet. The arrangement being such that, once such free communication is established, fluid escapes the upper chamber and the change in relative pressures above and below the main valve assembly causes the latter to unseat thereby permitting flow of the immersing fluid into the outlet and its substantially complete discharge. The cessation of flow of the immersing fluid allows the main valve assembly to revert to its seated position with the pilot stem cutting off free communication, and air penetrates the upper chamber and on replenishment of immersing fluid, a net downward pressure is created on the main valve assembly to keep it seated. The pilot valve has a hollow stem communicating to atmosphere above the normal full set level of fluid in the cistern. The main valve assembly and the hollow stem define therebetween a hollow annulus.
Patent FI-991273-A0 (FI)
Inventor: JAERVINEN VILLE
IPC: H04W4/02
Filed: 1999-06-03
Abstract: A method for transmitting a message in a communications service operating through a mobile telephone network, in which service a customer-specific user identifier, intended to conceal the real identity of the customer, is allocated to each customer (1, 2) of the communications service, and, in which method, a message addressed to at least one other customer (2) is received from a first customer (1), the user identifier of the customer sending the message is attached to the received message, and the message and the attached user identifier are forwarded to at least one other customer of the communications service.
Patent IL-57765-A0 (IL)
Title: 2-cyclopropyl-pyrimidin-4-yl-(thiono)(thiol)-phosphoric(phosphonic)acid esters and ester-amides,their preparation and their use as insecticides and acaricides
IPC: C07F9/6512
Filed: 1979-07-10
Abstract: O-alkyl-O-(2-cyclopropyl-6-substituted-methyl-pyrimidin-4-yl)-(thiono) (thiol) phosphoric (phosphonic) acid esters and ester-amides of the formula   <IMAGE>   in which R is alkyl, R1 is alkyl, alkoxy, alkylthio, alkylamino or phenyl, R2 is alkoxy or alkylthio, and X is oxygen or sulphur, which possess arthropodicidal properties.
Patent IL-59487-A0 (IL)
Title: Derivatives of 3-aminopropane-1,2-diol,their preparation and pharmaceutical compositions containing them
IPC: C07D303/22
Filed: 1980-02-28
Abstract: Derivatives of 3-aminopropane-1,2-diol of the formula    <IMAGE>  (I) in which Ar represents optionally substituted aryl, _n represents the number 0 or 1, and _a represents alkylene having 2 to 5 carbon atoms, the nitrogen atom and the oxygen atom, or, if _n is zero, the phenyl radical, being separated from one another by at least two carbon atoms, and R1 and R2, independently of one another, each represents hydrogen or lower alkyl, or together they represent lower alkylene, oxa-lower alkylene, thia-lower alkylene, aza-lower alkylene or N-lower alkyl-aza-lower alkylene, and salts of such compounds, processes for their manufacture, medicaments containing the new compounds and their use for the treatment of Angina pectoris and cardiac arrhythmia, and as blood pressure-reducing agents, as well as for the treatment of reactive or endogenic states of depression.
Patent IL-72165-A0 (IL)
Title: Beta-carboline derivatives and pharmaceutical compositions containing the same
IPC: A61P25/00
Filed: 1984-06-20
Abstract: Substituted  beta -carbolines of the formula I 
<IMAGE>
 in which
 R<3> denotes the 5-oxadiazolyl radical 
<IMAGE>
 where R' has the meaning C1-3-alkyl and C3-C6-alkyl and
 the alkoxycarbonyl radical -COOR'' where R'' has the meaning C1-4-alkyl,
 R<4> denotes hydrogen, methyl, ethyl and methoxymethyl and
 R<A> denotes the aryl radical 
<IMAGE>
 and the aralkyl radical 
<IMAGE>
 where X has the meaning C1-12-alkyl, it being possible for the alkyl radical to be straight-chain, branched, saturated or unsaturated and for a CH2 group to be substituted by a carbonyl group, and where R''' has the meaning fluorine, chlorine, bromine or iodine, C1-3-alkyl, C1-3-alkoxy, C1-5-acyloxy, phenyl, C2-5-alkylenedioxy, trifluoromethyl, nitrilo, nitro or an amino group -NR<IV>R<V> where
 R<IV> and R<V> have the meaning hydrogen, C1-3-alkyl, C1-5-acyl or phenyl, it being possible for R<IV> and R<V> to be identical or different and to form a 3-6-membered hetero ring system together with the amino nitrogen atom,
 it being possible for the substituent R''' to occur once or more on the aryl radical in an identical or different manner, and a process for their preparation are described. 
<??>The compounds have an action on the central nervous system and are thus suitable as psychopharmaceuticals.
Patent IL-76563-A0 (IL)
Title: Pharmaceutical preparations containing prostaglandins
IPC: A61K31/575
Filed: 1985-10-04
Abstract: Combination products containing an antigestagen, a glucocorticoid and a prostaglandin are suitable for combined use in inducing labor or terminating pregnancy.
Patent AU-PN363995-A0 (AU)
Title: Electrochemical cell
IPC: G01N27/416
Filed: 1995-06-19
Abstract: A method for determining the concentration of reduced (or oxidised) form of a redox species in an electrochemical cell of the kind comprising a working electrode and a counter electrode spaced from the working electrode by a predetermined distance, said method comprising the steps of: (1) applying an electric difference between the electrodes; (2) selecting the potential of the working electrode such that the rate of electro-oxidation of the reduced form (or electro-reduction of the oxidised form) of the species is diffusion controlled, (3) selecting the spacing between the working electrode and the counter electrode so that reaction products from the counter electrode arrive at the working electrode; (4) determining current as a function of time after application of the potential and prior to achievement of a steady state; (5) estimating the magnitude of the steady state current, and (6) obtaining from the change in current with time and magnitude of the steady state current, a value indicative of the diffusion coefficient and/or of the concentration of the reduced form (or the oxidised form) of the species. Also disclosed is an apparatus for determining the concentration of a redox species in an electrochemical cell comprising: an electrochemical cell having a working electrode and a counter (or counter/reference) electrode, means for applying and electric potential difference between said electrodes, means for measuring the change in current with time, and characterised in that the working electrode is spaced from the counter electrode by less than 500µm.
Patent FI-20012168-A0 (FI)
Inventor: BLOMQVIST RAINER
IPC: D21F11/00
Filed: 2001-11-09
Abstract: The present invention relates to a method and apparatus for foam forming, wherein fibrous foam suspension is introduced from the head box ( 78, 178 ) of a production machine to the web forming section thereof. At least one solid material is mixed into the foam in the head box ( 78, 178 ). The method and the apparatus of the invention are particularly suitable for manufacturing various web-like products of cellulose, glass fiber, aramide, sisal, or other corresponding fibre material.
Patent FI-20031286-A0 (FI)
Inventor: KIRVESMAEKI JARMO
IPC: D21F1/02
Filed: 2003-09-09
Abstract: A headbox apparatus of a paper machine or equivalent has a body (11). Dilution water (arrow L2) is conducted through at least two rows of ducts (12a1, 12a2 . . . ) into each body mixing chambers (13a1, 13a2 . . . ). Each mixing chamber (13a1, 13a2 . . . ) is limited by vertical walls (T1), a bottom wall (T2) and a covering wall (T3), and a partition wall (16a1, 16a2 . . . ). The ducts (14a1.1, 14a1.2 . . . ) on the inlet side of the mixing chamber extend into the mixing chamber (13a1, 13a2 . . . ) at a distance (h1) from the ducts (15a1.1, 15a1.2 . . . , 15a2.2 . . . ) on the outlet side of the mixing chamber (13a1, 13a2 . . . ), whereby an annular gap (D1) is left between the aligned duct (14a1.1, 14a1.2 . . . 14a2.1, 14a2.2 . . . ) on the inlet side and the duct (15a1.1, 15a1.2 . . . , 15a2.1, 15a2.2 . . . ) on the outlet side. Each mixing chamber (13a1, 13a2 . . . ) is filled by dilution water which is conducted through the annular gap (D1) to join the stock (m1).
Patent FI-20070782-A0 (FI)
Inventor: VALJUS PETTERI
IPC: B66B/
Filed: 2007-10-18
Abstract: The invention relates to an elevator provided with a safety gear arrangement, the elevator including at least an elevator car arranged to travel back and forth substantially vertically along guide rails, at least two safety gear mechanisms disposed in conjunction with the elevator car and at least one speed limiter, which includes at least a speed limiter pulley, a diverting pulley and a speed limiter rope fitted as a loop around at least the speed limiter pulley and the diverting pulley, the speed limiter rope being connected at least to a first safety gear mechanism. A second safety gear mechanism has been arranged to be triggered after the triggering of the first safety gear mechanism.
Patent FI-20075472-A0 (FI)
Inventor: KOKKONEN KARI
IPC: D21F/
Filed: 2007-06-20
Abstract: The invention relates to a method in monitoring the condition of felt (H) in a pa¬ per machine, a board machine or equivalent. In the method according to the invention, based on air volume (Q) of a UhIe box (11), an area (A) and vacuum (?p) of the UhIe box, an air permeability index (K) of the felt (H) is calculated. It is the air volume (Q) having permeated the felt (H) via a suction surface of the UhIe box over the area (A) of the UhIe box and vacuum (?p) being across the felt.
Patent IL-104112-A0 (IL)
Title: 5-or 6-deoxy hexofuranose monosaccharide derivatives and pharmaceutical compositions containing the same
IPC: C07H19/04
Filed: 1992-12-16
Abstract: The compounds of this invention are 5- or 6-deoxy hexose monosaccharides having a saturated nitrogen-containing heterocycle at the 5- or 6-position bound through the nitrogen atom. The saturated nitrogen-containing heterocycle substituent is shown by the following formula:   <IMAGE>   where X is CH2, NH or O; and n ranges from 3-6. These hexose monosaccharides may also be ethereally substituted at least one other position. The compounds exhibit anti-proliferative and anti-inflammatory activity. Methods of preparation, pharmaceutical compositions containing the compounds and methods of treating inflammatory and/or autoimmune disorders employing the compounds are disclosed.
Patent IL-107196-A0 (IL)
Title: Method for preparation of polysuccinimide from maleamic acid and a composition comprising it
IPC: C11D3/37
Filed: 1993-10-05
Abstract: A method for producing polysuccinimide is provided. Thermal polymerization of maleamic acid at a temperature of from about 160 DEG C to about 330 DEG C produces polysuccinimide. The reaction is optionally conducted in the presence of one or more processing aids, solvents or diluents. The polysuccinimide is particularly useful as a detergent additive.
Patent IL-109543-A0 (IL)
Title: Treatment for toxoplasmosis
IPC: A61K31/445
Filed: 1994-05-04
Abstract: A method of reducing the severity of toxoplasmosis resulring from infection of a patient with Toxoplasma gondii by administering to a patient in need of such treatment, either after infection or before exposure to infection, a therapeutically effective amount of a compound that is a spiropiperidyl derivative of rifamycin S, wherein the derivative comprises an imidazole ring that includes carbons at positions 3 and 4 of the rifamycin ring, the carbon at position 2 of the imidazole ring also being a ring carbon at position 4 of a piperidine ring system, thereby forming a spiropiperidyl ring system, the spiropiperidyl ring system optionally comprising a lower hydrocarbon substituent on the nitrogen of the piperidine.
Patent IL-109781-A0 (IL)
Title: Variable stiffness balloon catheter
IPC: A61M25/00
Filed: 1994-05-25
Abstract: This invention is a single-lumen balloon catheter and assembly having a variable stiffness shaft that allows for greater guidewire trackability and proximal pushability than previous designs. The catheter has an elongate tubular body that is made of inner and outer coaxial tubes, the inner tube being made of proximal and distal sections, the proximal section being stiffer than the distal section and the distal section being stiffer than the outer tube.
Patent IL-111351-A0 (IL)
Title: Method of making calcification-resistant bioprosthetic tissue
IPC: C14C3/04
Filed: 1994-10-20
Abstract: A method of treating a collagenous biomaterial, such as porcine aortic valve leaflets or bovine pericardium, by exposing the biomaterial to an alcohol to inhibit in vivo calcification. The biomaterial, preferably glutaraldehyde-pretreated, is subjected to an aqueous solution of 60% to 80% lower aliphatic alcohol, such as ethanol for a period of at least 20 minutes, and preferably, 24 to 72 hours. The biomaterial is rinsed, and then stored in either a glutaraldehyde-free environment or an ethanolic solution of glutaraldehyde. In some embodiments, the treatment solutions include an additional anticalcification agent which may be a soluble salt of a metallic cation, such as Al+3 or Fe+3.
Patent IL-111925-A0 (IL)
Title: Preparation of agents containing virus - inactivated vitamin k-dependent plasma components, protein c and protein s by membrane chromatography
IPC: A61K38/46
Filed: 1994-12-07
Abstract: Disclosed is a process for preparing agents containing virus-inactivated vitamin K-dependent plasma components as well as protein C, protein S, factors II, VII, IX and/or X as well as combinations thereof, such as, for example, PPSB preparations, wherein a source containing these components is subjected to a appropriate separation procedures, especially by using membrane-chromatographic methods.
Patent IL-112125-A0 (IL)
Title: Quinazolinone - containing pharmaceutcial compositions and methods for the use thereof
IPC: C07D401/06
Filed: 1994-12-22
Abstract: The invention provides a composition for attenuating mesangial cell proliferation, comprising an amount of a compound of formula (I) wherein: R>1< is a member of the group consisting of hydrogen, halogen, nitro, benzo, lower alkyl, phenyl and lower alkoxy; R>2< is a member of the group consisting of hydroxy, acetoxy, and lower alkoxy, and R>3< is a member of the group consisting of hydrogen and lower alkenoxy-carbonyl; effective to attenuate mesangial cell proliferation.
Patent IL-118358-A0 (IL)
Title: Process for the preparation of a dicarboxylic acid dichloride
IPC: C07C235/16
Filed: 1996-05-22
Abstract: The present invention refers to a Process for the preparation of S-(-)-5-[[2-(acetyloxy)-1-oxopropyl]amino]-2,4,6-triiodo-1,3-benzenedicarboxylic acid dichloride of formula (I) comprising the reaction between S-(-)-[2-(acetyloxy)]propionic acid chloride and 5-amino-2,4,6-triiodo-, 1,3-benzenedicarboxylic acid dichloride, in an aprotic dipolar solvent and in presence of a halogenhydric acid.
Patent IL-120236-A0 (IL)
Title: Surgical instruments and procedures for stabilizing the beating heart during coronary artery bypass graft surgery
IPC: A61B17/11
Filed: 1997-02-17
Abstract: The invention is methods and devices which a surgeon may use to stabilize the beating heart during a surgical procedure on the heart. Pursuant to the invention, a stabilizing device is introduced through an opening in the chest and brought into contact with the beating heart. By contacting the heart with the device and by exerting a stabilizing force on the device, the motion of the heart caused by the contraction of the heart muscles is effectively eliminated such that the heart is stabilized and the site of the surgery moves only minimally if at all. Typically, in separate steps, the surgeon contacts the heart with the stabilizing means, assesses the degree of movement of the anastomosis site, and exerts a force on the stabilizing means such that the contraction of the beating heart causes orgy minimal excess motion at the surgery site. By fixing the position of the stabilizing means in a configuration where the motion of the beating heart is effectively eliminated, the surgeon is able to stabilize the beating heart for the duration of the procedure. The stabilizing means may be attached to a rigid support or may be attached to a semi-rigid support which is rendered motionless mechanically, chemically, or by human intervention. In certain preferred embodiments, the stabilizing means is affixed to a semi-rigid support which is caused to become rigid, by any of a variety of techniques, such that the position of the stabilizing means becomes fixed by the support, and the heart remains substantially motionless for the duration of the procedure. <IMAGE>
Patent IL-120892-A0 (IL)
Title: Method for obtaining a dental occlusion map
IPC: A61C19/05
Filed: 1997-05-22
Abstract: A method for obtaining a dental occlusion map of a three-dimensional virtual computer model of teeth of upper and lower jaws of a mouth. The occlusion map indicates the distances between opposite regions on facing surfaces of opposite teeth of the upper and lower jaws of the mouth. The method includes the steps of determining the distances between opposite regions on opposite teeth of the upper and lower jaws of the mouth, and setting up a correspondence between the determined distances and regions on a mapping surface.
Patent IL-122905-A0 (IL)
Title: Pharmaceutical compositions form of a solid dispersion comprising a rapamycin or 33-epi-chloro-33-desoxy-ascomycin
IPC: A61K47/36
Filed: 1996-07-12
Abstract: A pharmaceutical composition for oral administration in the form of a solid dispersion comprising an ascomycin or a derivative thereof and a carrier medium.
Patent IL-125536-A0 (IL)
Title: Preparation stimulating nail growth
IPC: A61K8/49
Filed: 1997-01-23
Abstract: PCT No. PCT/EP97/00311 Sec. 371 Date Feb. 11, 1998 Sec. 102(e) Date Feb. 11, 1998 PCT Filed Jan. 23, 1997 PCT Pub. No. WO97/28790 PCT Pub. Date Aug. 14, 1997A nail varnish comprising a compound having a vasodilating action and a water-insoluble film-forming agent is suitable for treatment of growth disturbances of the nail.
Patent IL-139346-A0 (IL)
Title: Process for selective oxidation of primary alcohols
IPC: C07B33/00
Filed: 1999-05-04
Abstract: Primary alcohols, especially in carbohydrates, can be selectively oxidized to aldehydes and carboxylic acids in a low-halogen process by using a peracid in the presence of a catalytic amount of a di-tertiary-alkyl nitroxyl (TEMPO) and a catalytic amount of halide. The halide is preferably bromide and the process can be carried out at nearly neutral to moderately alkaline pH (5-11). The peracid can be produced or regenerated by means of hydrogen peroxide or oxygen. The process is advantageous for producing uronic acids and for introducing aldehyde groups which are suitable for crosslinking and derivatization.
Patent IL-139615-A0 (IL)
Title: An insect capturing device
IPC: A01M3/00
Filed: 1999-05-07
Abstract: The device comprises a handle (2), a head (4) having bristles (5) and an actuator to cause the bristles to surround and capture an insect (Fig 9). The bristles (5) may be arranged in concentric rings. The handle (2) may have a trigger (11) which allows a user to move the bristles (5) between a diverged position and a converged position in which an insect is entrapped without being injured. The device may then be carried outdoors and the bristles again moved to the diverged position so that the insect is released harmlessly.
Patent IL-152495-A0 (IL)
Title: Noncoherent integrator for signals with high acceleration uncertainty
IPC: G01S7/288
Filed: 2001-04-23
Abstract: A radar signal processing method and system for detecting target objects of unknown acceleration and having low SNRs which reduces the computational burdens and provides a more efficient way of performing the operation of non-coherent integration. Radar signal processing is conducted according to a predetermined scheme in which partially processed received signal data is selectively stored and reused, reducing redundant processing. The radar system receives return signals frequency shifted from a predetermined frequency scheme by unknown amounts. The received signals are coherently integrated transforming them into frequency domain templates which are non-coherently arranged into an array matrix. The data of the frequency domain templates are processed to form presums which are stored for use in forming higher level presums and for forming acceleration bins. Once the acceleration bins have been formed, they are analyzed to detect the presence of target object return signals.
Patent IL-161351-A0 (IL)
Title: ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR delta
IPC: C07D413/12
Filed: 2002-10-09
Abstract: A compound represented by the formula (I) or a salt of the compound, and a PPAR- delta  activator which contains the compound or salt as the active ingredient: <CHEM> (wherein A represents O or S; B<1> represents N, etc.; B<2> represents O, etc.; each of X<1> and X<2> represents O, S, a bond, etc.; Y represents C1-8 alkylene chain; Z represents O or S; R<1> represents aryl, etc. which can have substituents; R<2> represents C1-8 alkyl, etc.; R<3> represents C1-8 alkyl, C2-8 alkenyl, etc.; each of R<4> and R<5> represents hydrogen, C1-8 alkyl, etc.; and R<6> represents hydrogen, etc.; provided that each of Z and R<3> is attached to the benzene ring, and X<2> is not attached to the benzene ring).
Patent IL-166310-A0 (IL)
Title: Administering apparatus with return-blocked pistonrod
IPC: A61M5/50
Filed: 2005-01-14
Abstract: An administering apparatus including a casing, a reservoir, a piston accommodated in the reservoir such that it can be shifted in an advancing direction, a piston rod which acts on the piston in the advancing direction and forms a first locking mechanism, a second locking mechanism which cannot be moved counter to the advancing direction, a lock element row formed by successively arranged first locking elements, extending in the advancing direction, and formed by one of the locking mechanisms, and a second lock element formed by the other locking mechanism and engaged with the lock element row, wherein it engages with a lock element gap of the lock element row, wherein the second lock element is moved out of engagement by a movement, against an elasticity force, of the piston rod in the advancing direction, but, when engaged, counteracts a movement of the piston rod counter to the advancing direction with a resistance force greater than the elasticity force to prevent the piston rod from moving counter to the advancing direction. In some embodiments, either or both the first and second locking mechanisms form a securing element at one or both ends with respect to the advancing direction, the securing element counteracting a movement of the piston rod counter to the advancing direction with a locking force greater than the resistance force.